Aerie Pharmaceuticals Inc - Company Profile
Powered by 
All the sales intelligence you need on Aerie Pharmaceuticals Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Aerie Pharmaceuticals Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Aerie Pharmaceuticals Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Aerie Pharmaceuticals Inc patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| US11590123B2 | Grant | Ophthalmic compositions | A61K31/472; A61K31/5575; A61K45/06; A61K47/02; A61K47/186; A61K47/26; A61K9/0048; A61K9/08; | February 28, 2023 |
| EP3811943B1 | Grant | VERBINDUNG ZUR VERWENDUNG IN DER BEHANDLUNG VON AUGENKRANKHEITEN | A61K31/472; A61K31/4725; A61K31/557; A61K31/5575; A61K31/559; A61K47/10; A61K47/26; A61K47/54; A61K47/55; A61K9/0048; A61K9/08; A61P27/02; A61P27/06; A61P43/00; C07D217/22; C07D409/12 | February 22, 2023 |
| EP3917923A4 | Search Report | VERBINDUNGEN, ZUSAMMENSETZUNGEN UND VERFAHREN ZUR BEHANDLUNG VON MYOPIE | A61K31/46; A61K31/506; A61K9/0048; A61P27/10; C07D213/30; C07D213/40; C07D239/26; C07D405/12; C07D409/12; C07D451/02; C07D451/04; C07D451/06; C07D471/08; C07D495/04 | February 08, 2023 |
| AU2019337703B2 | Grant | Aryl cyclopropyl-amino-isoquinolinyl amide compounds | A61P1/00; A61P27/06; C07D217/02; C07D217/22; C07D401/12; C07D401/14; C07D405/12; C07D413/12; C07D417/12; C07D417/14 | February 02, 2023 |
| US20230002404A1 | Application | HETEROBICYCLIC CARBOXAMIDES AND USES THEREOF | C07D471/04; C07D495/04; C07D513/04 | January 05, 2023 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer